Viking Therapeutics Inc (NASDAQ: VKTX): Analyst View Points To Future Growth
Fidelity Management & Research Co has recently announced that it has increased stake in Viking Therapeutics Inc (NASDAQ:VKTX) by 0.19%. After grabbing 14.94 million shares, the institutional investor is now in possession of 28523.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 14.94% having worth around $182.58 million. […]
Viking Therapeutics Inc (NASDAQ: VKTX) – Not A Clear Buying Opportunity?
Fidelity Management & Research Co has recently announced that it has increased stake in Viking Therapeutics Inc (NASDAQ:VKTX) by 0.19%. After grabbing 14.94 million shares, the institutional investor is now in possession of 28523.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 14.94% having worth around $146.57 million. […]
